Relation of fasting insulin related to insertion/deletion polymorphism of angiotensin-converting enzyme-gene and cardiac mass in never-treated patients with systemic hypertension

American Journal of Cardiology

Volumn 92, Issue 10, 2003, Pages 1234-1237

  Ceravolo, Roberto ^b   Maio, Raffaele ^b   Cuda, Giovanni ^b   Scozzafava, Angela ^b   Sciacqua, Angela ^b   Vatrano, Marco ^b   Bellieni, Giancarlo ^b   D'Angelo, Gianfranco ^b   Schipani, Francesco A ^b   Sesti, Giorgio ^b   Perticone, Francesco ^a  

^a Policlinico Mater Domini   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; INSULIN;

ADULT; ARTICLE; ASSOCIATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; HEART VOLUME; HUMAN; HYPERTENSION; INSULIN METABOLISM; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 10744230760     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.07.043     Document Type: Article

References (20)

1. Perticone F., Ceravolo R., Iacopino S., Cloro C., Ventura G., Maio R., Gulletta E., Perrotti N., Mattioli P.L. Relationship between angiotensin-converting enzyme gene polymorphism and insulin resistance in never-treated hypertensive patients. J Clin Endocrinol Metab. 86:2001;172-178.
2. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man . Diabetologia. 28:1985;412-419.
3. Haffner S.M., Miettinen H., Stern M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 20:1997;1087-1092.
4. World Health Organization International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 17:1999;151-183.
5. Sahn D.J., De Maria A., Kisslo J., Weyman A. The Committee on M-mode Standardization of the American Society of Echocardiography recommendation regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurement . Circulation. 58:1978;1072-1080.
6. Rigat B., Hubert C., Alhens-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86:1990;1343-1346.
7. Shanmugam V., Sell K.W., Saha B.K. Mistyping ACE heterozygotes. PCR Methods Appl. 3:1993;120-121.
8. Hurst P.L., Lovell-Smith C. Optimized assay for serum angiotensin converting enzyme activity. Clin Chem. 7:1981;2048-2052.
9. Perticone F., Maio R., Cosco C., Ceravolo R., Iacopino S., Chello M., Mastroroberto P., Tramontano D., Mattioli P.L. Hypertensive left ventricular remodeling and ACE-gene polymorphism. Cardiovasc Res. 43:1999;192-199.
10. Higashi Y., Oshima T., Sasaki N., Ishioka N., Nakano Y., Ozono R., Yoshimura M., Ishibashi K., Matsuura H., Kajiyama G. Relationship between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension. Hypertension. 29:1997;280-285.
11. Ferrannini E., Buzzigogli G., Bonadonna R., Giorico M.A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 317:1987;350-357.
12. Denker P.S., Pollock V.E. Fasting serum insulin levels in essential hypertension a meta-analysis . Arch Intern Med. 152:1992;1649-1651.
13. Caro J.F. Insulin resistance in obese and non obese man. J Clin Endocrinol Metab. 3:1991;6916-6995.
14. Laakso M., Edelman S.V., Brechtel G., Baron A.D. Impaired insulin mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 1:1992;1076-1083.
15. Panza J.A., Quyyumi A.A., Brush J.E. Jr, Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 3:1990;22-27.
16. Perticone F., Ceravolo R., Maio R., Ventura G., Zingone A., Perrotti N., Mattioli P.L. Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension. 31:1998;900-905.
17. Perticone F., Ceravolo R., Iacopino S., Cloro C., Ventura G., Maio R., Gulletta E., Perrotti N., Mattioli P.L. Relationship between angiotensin-converting enzyme gene polymorphism and insulin resistance in never-treated hypertensive patients. J Clin Endocrinol Metab. 86:2001;172-178.
18. Dixon B.S., Sharma R.V., Dickerson T., Fortune J. Bradykinin and angiotensin II activation of protein kinase C in arterial smooth muscle . Am J Physiol. 266:1994;C1406-C1420.
19. Smrcka A.V., Hepler J.R., Brown K.O., Sternweis P.C. Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Nature. 251:1991;804-807.
20. Folli F., Kahn C.R., Hansen H., Bouchie J.L., Feener E.P. Angiotensin II inhibits insulin signaling in aortic smooth muscle cell at multiple levels. J Clin Invest. 9:1997;2158-2169.